As of 2025-05-23, the Relative Valuation of Neogenomics Inc (NEO) is (13.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.40 USD, the upside of Neogenomics Inc based on Relative Valuation is -281.9%.
The range of the Relative Valuation is (13.28) - (14.39) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 25.9x | 23.9x |
| Forward P/E multiples | 19.6x - 23.9x | 20.8x |
| Fair Price | (13.28) - (14.39) | (13.46) |
| Upside | -279.4% - -294.4% | -281.9% |
| Date | P/E |
| 2025-05-20 | -13.25 |
| 2025-05-19 | -13.37 |
| 2025-05-16 | -13.45 |
| 2025-05-15 | -13.00 |
| 2025-05-14 | -13.20 |
| 2025-05-13 | -13.87 |
| 2025-05-12 | -14.11 |
| 2025-05-09 | -13.35 |
| 2025-05-08 | -13.48 |
| 2025-05-07 | -13.27 |
| 2025-05-06 | -12.75 |
| 2025-05-05 | -13.00 |
| 2025-05-02 | -12.77 |
| 2025-05-01 | -12.04 |
| 2025-04-30 | -10.61 |
| 2025-04-29 | -10.91 |
| 2025-04-28 | -16.54 |
| 2025-04-25 | -17.03 |
| 2025-04-24 | -16.74 |
| 2025-04-23 | -16.44 |
| 2025-04-22 | -16.17 |
| 2025-04-21 | -15.89 |
| 2025-04-17 | -15.84 |
| 2025-04-16 | -15.86 |
| 2025-04-15 | -15.76 |
| 2025-04-14 | -16.12 |
| 2025-04-11 | -15.46 |
| 2025-04-10 | -14.76 |
| 2025-04-09 | -15.13 |
| 2025-04-08 | -13.60 |
| 2025-04-07 | -14.65 |
| 2025-04-04 | -14.56 |
| 2025-04-03 | -14.46 |
| 2025-04-02 | -15.62 |
| 2025-04-01 | -15.51 |
| 2025-03-31 | -15.74 |
| 2025-03-28 | -15.96 |
| 2025-03-27 | -15.72 |
| 2025-03-26 | -15.61 |
| 2025-03-25 | -16.52 |
| 2025-03-24 | -16.85 |
| 2025-03-21 | -16.35 |
| 2025-03-20 | -16.47 |
| 2025-03-19 | -16.50 |
| 2025-03-18 | -15.94 |
| 2025-03-17 | -16.32 |
| 2025-03-14 | -16.30 |
| 2025-03-13 | -15.79 |
| 2025-03-12 | -16.97 |
| 2025-03-11 | -18.05 |